Pre-Market
S&P 500 $771.77 +0.28% DOW $521.14 +1.07% NASDAQ $728.00 -0.13% BTC $82,527 +1.98%
VRTX
Vertex Pharmaceuticals Inc
NASDAQ HEALTHCARE
$508.75
+$10.25 (+2.06%)
Delayed 15 min · Oct 16, 12:14 PM UTC
Open
$514.91
High
$517.68
Low
$507.21
Prev Close
$498.50
Volume
2.26M

Price Chart

About Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

📊 HEALTHCARE 🏭 BIOTECHNOLOGY 🌍 USA

VRTX News

BofA cuts target for Vertex Pharma stock from USD 672 to USD 667
ad-hoc-news.de • 2h ago
IgA Nephropathy Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences
StreetInsider • 14h ago Somewhat-Bullish
Insmed (INSM) Could Be 50% Undervalued After TPIP Phase 3 Push
Simply Wall Street • 14h ago
UBS lifts PTC Therapeutics stock target to USD 90.00
ad-hoc-news.de • 16h ago Somewhat-Bullish
BofA cuts target for Vertex Pharmaceuticals stock to USD 667
ad-hoc-news.de • Yesterday
Learn Why The Bull Case For Travere Therapeutics Stock Could Change Following FILSPARI Kidney Data
Simply Wall Street • Yesterday
CapsoVision to present new AI-enabled capsule e...
Pluang • Yesterday
Did Licensing Deal Just Shift Biohaven (BHVN) Investment Narrative?
Simply Wall Street • Yesterday Somewhat-Bullish

Key Statistics

Market Cap
126.35B
P/E Ratio
28.87
EPS
$17.27
Beta
0.281
52W High
$560.25
52W Low
$403.16
Div Yield
N/A
Avg Volume
2.26M

Related Stocks

AAPL
Apple
MSFT
Microsoft
GOOGL
Alphabet
AMZN
Amazon
TSLA
Tesla

💬 Discussion

Loading...
Loading comments...